(TSX:DZR) todayreported that it has licensed a second well, 102/06-18-48-1 W4, on itsdeveloping Lloydminster oil play.The second location is an offset to its initial oil well 11-18-48-1 W4,announced June 1, 2009, and is the first of a multi-well program in the area.Diaz is operator of the well and holds a 50% working interest. LaporteTel: 646-205-0291Copyright 2009, Market Wire, All rights reserved.-0-. With theadoption of NCM as an open standard, platform vendors and handset vendorsinterested in high speed data rate capabilities are expected to leverage theNCM solution to achieve truly high-speed data throughput."MCCI, as a primary contributor to and technical editor of the NCMspecification, has already deployed a preliminary version of NCM, called EarlyNCM (ENCM) to prove the viability and advantages of this new protocol,"explains Terry Moore, MCCI CEO. Photos/Multimedia Gallery Available: http:// Chase, 919-277-1158; Copyright Business Wire 2009. For more information, please call (800) 517-5282 or visit. Rite Track is located at 8655 Rite Track Way, West Chester,OH 45069. SPC-011 also intersected 1.6m of 4.32 g/t gold in altered sandstones,from 197.55m and below the historical Serra Pelada pit.
"A lot of them are offshore.It's very difficult to stopsomebody that's in another country, particularly one where thelaws aren't friendly to the United States and it can be verychallenging," he said. Gary Collett, Dan Cook,Mark Becker and Ashley Pope of global real estate services firm Cushman &Wakefield, are providing brokerage services for the remaining 234,000 squarefeet - divisible to 94,500 square feet - of industrial space."This prime real estate offers a unique opportunity with its location adjacentto the Dallas-Fort Worth-Arlington metro area and two international intermodaltransportation hubs," Collett says. The 3.5 cm deviceprovides physicians with another option beyond the more complex transcorporealprocedure for treating patients who have a urethra smaller than 4.0 cm,currently the smallest diameter cuff available. LONDON, Sep 09 (MARKET WIRE) -- Clenergen Corporation CEO Mark Quinn today announced the acquisition ofan exclusive intellectual property license for use in India and Sri Lankafrom Star Biotechnology Ltd which will give his company immediate accessto the technology and know-how required to increase the rate of biomassproduction and so assist the generation of clean electricity throughgasification."This is a significant source of plant science and expertise forClenergen and will literally accelerate the development of our ambitionsin the field. or its subsidiaries in theUnited States and in other countries. His best previous finish was second place in the US$5KPot-Limit Omaha event at the 2007 WSOP.WSOPE Event 2, a half Pot-Limit Hold 'em and half Pot-Limit Omahatournament with a buy-in of GBP2,500, attracted 158 of the world's bestplayers to the Empire Casino in London.
SecondMarket, which has conductedmore than $1 billion in transactions in 2009, has more than 4,000 participants,including global financial institutions, hedge funds, private equity firms,mutual funds, corporations and other institutional and accredited investors thatcollectively manage over $1 trillion in assets For more information, visit Copyright 2009 SecondMarket, Inc (Member FINRA, MSRB andSIPC). Cette acquisition coïncide avec notre stratégie d'expansion endirection de segments de marché adjacents et nous permettra d'accomplir notremission de potentialisation de la qualité de vie des patients et d'améliorationdes résultats pour nos clients». Thisinformation may be of interest to the company's shareholder and potentialshareholders, since it outlines Redwood Capital's performance over thelast year and some discussion of management's expectations for the 2010fiscal year. "We are excited about the enormous potential of our new association with ParagonHealth," said Steve Schelhammer, CEO of Phytel. Italso provides GeneNews with opportunities to realize additional commercialvalue through potential licensing arrangements and the further development ofour own pipeline of 'Sentry' products."The Sentinel Principle(R), a platform technology developed by GeneNews, isbased on the concept that all clinical conditions and body states, includingthose resulting from disease or in response to treatment, generatecharacteristic gene expression signatures in the blood as a result of theclose physiological interaction of blood with the cells, tissues and organs ofthe human body. Forward-lookingstatements include statements as to the potential benefits of, and demandfor, DragonWave's products.
